Julian Garcia-Feijoo to Intravitreal Injections
This is a "connection" page, showing publications Julian Garcia-Feijoo has written about Intravitreal Injections.
Connection Strength
0.541
-
Long-term effect of intravitreal ranibizumab therapy on retinal nerve fiber layer in eyes with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2019 Jul; 257(7):1459-1466.
Score: 0.164
-
ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up. Graefes Arch Clin Exp Ophthalmol. 2017 Nov; 255(11):2091-2098.
Score: 0.145
-
Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits. Eur J Pharm Sci. 2017 May 30; 103:19-26.
Score: 0.141
-
Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment. Am J Ophthalmol. 2011 Mar; 151(3):529-34.
Score: 0.092